Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Mingxin Pharmaceutical is a comprehensive pharmaceutical enterprise located in the Mingshui Economic and Technological Development Zone of Jinan, China. Founded in 1989, the company has established itself as a significant manufacturer of both active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, and injections. Its product portfolio is primarily focused on chronic disease management, with a strong emphasis on treatments for type 2 diabetes, cardiovascular conditions, and gastrointestinal disorders. The company operates multiple production lines that are fully compliant with national Good Manufacturing Practice (GMP) standards. Jinan Mingxin serves a broad market, providing essential generic medications like metformin and gliclazide to healthcare providers across China and internationally. The firm continues to invest in manufacturing technology to maintain its competitive edge in the generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 济南明鑫.